Calidi Biotherapeutics, Inc.

CLDI · AMEX
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$5-$6-$5-$4
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$1$1$1
Change in WC-$0-$0-$3-$2
Other Non-Cash$1$0-$0-$0
Operating Cash Flow-$4-$5-$7-$5
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0-$0-$0-$0
Financing Activities
Debt Repay.-$1-$0-$2-$0
Stock Issued$10$0$10$12
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$0-$0$1
Financing Cash Flow$9-$0$8$13
Forex Effect-$0$0$0$0
Net Chg. in Cash$5-$5$1$8
Supplemental Information
Beg. Cash$5$11$10$2
End Cash$10$5$11$10
Free Cash Flow-$4-$5-$7-$5